4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0000899243-20-027690
Director acquired 4,203,757 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| COHEN ALAIN J Director | 2020-10-06 | Conversion | +237,149 | 237,149 | I | ||
| COHEN ALAIN J Director | 2020-10-06 | Conversion | +1,482,183 | 1,719,332 | I | ||
| COHEN ALAIN J Director | 2020-10-06 | Conversion | +2,484,425 | 2,484,425 | I | ||
| Derivatives | |||||||
| COHEN ALAIN J Director | 2020-10-06 | Conversion · Series Seed Preferred Stock | −2,000,000 | 0 | I | ||
| COHEN ALAIN J Director | 2020-10-06 | Conversion · Series A Preferred Stock | −12,500,000 | 0 | I | ||
| COHEN ALAIN J Director | 2020-10-06 | Conversion · Series B Preferred Stock | −20,952,403 | 0 | I | ||
Loading xslF345X03/doc4.xml…